|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/21 | (2006.01) |
| A61P 1/16 | (2006.01) | ||
| A61P 31/14 | (2006.01) |
| (11) | Number of the document | 3416675 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17753966.5 |
| Date of filing the European patent application | 2017-02-17 | |
| (97) | Date of publication of the European application | 2018-12-26 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-24 |
| (46) | Date of publication of the claims translation | 2021-06-25 |
| (86) | Number | PCT/US2017/018466 |
| Date | 2017-02-17 |
| (87) | Number | WO 2017/143253 |
| Date | 2017-08-24 |
| (30) | Number | Date | Country code |
| 201662297759 P | 2016-02-19 | US |
| (72) |
MARTINS, Eduardo Bruno, US
|
| (73) |
Eiger Biopharmaceuticals, Inc.,
2155 Park Boulevard, Palo Alto, CA 94306,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Hepatito delta viruso infekcijos gydymas interferonu lambda |
| TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA |
| Payment date | Validity (years) | Amount | |
| 2025-01-20 | 9 | 208.00 EUR |
| 2026-02-17 |